Gastrointestinal stromal tumors (GIST) are rare mesenchymal tumors and were among the first solid tumor types for which such a novel treatment (in this case imatinib) became available. The ...
AZoM on MSN5h
New 3D Model for Gastric Cancer ResearchA novel 3D bioprinted gastric cancer model using patient-derived tissues predicts drug responses, enhancing personalized ...
Patients with non-metastatic GIST treated with neoadjuvant TKIs prior to surgery experienced a benefit which led to less ...
A collaborative research team from POSTECH has successfully developed a gastric cancer model using 3D bioprinting technology ...
Rare cancers are less known and pose challenges due to limited research and diagnostic difficulties. Environmental factors, ...
Taken together, the above findings suggest that tumor stroma is far from a passive bystander during tumor metastases. Tumor cells influence stromal changes including remodeling of the ECM ...
Management trends and outcomes of appendiceal cancers: A National Cancer Database study. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This abstract does not ...
GSK has announced that it will be expanding its gastrointestinal (GI) cancer pipeline by acquiring IDRx in a deal ... being developed as a first- and second-line therapy for gastrointestinal stromal ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback